 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning Micromet Inc.
|
-
Micromet's BiTE Antibody Blinatumomab Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma
(10 Jun 2008)
Micromet, Inc. presented an update of an ongoing phase 1 clinical trial for its BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the 10th International Conference on Malignant Lymphomas (ICML) in Lugano, Switzerland. The new data with the ...
-
Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110
(28 Apr 2008)
The First BiTE Antibody for Treatment of Solid Tumors
Micromet, Inc. announced the start of a phase 1 clinical trial with its BiTEŽ antibody MT110. The study will explore the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of MT110 in patients with lung and gastrointestinal cancers. ...
-
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
(14 Sep 2007)
Micromet, Inc. announced the appointment of Mark Reisenauer as Senior Vice President and Chief Commercial Officer.Mark Reisenauer joins Micromet from Abbott, where he was the General Manager of the Oncology Franchise from 2002 to 2006 and most ...
-
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize Antibody D93
(20 Mar 2007)
Start of Phase 1 Clinical Trial Planned for the Second Half of This Year
Micromet, Inc. and TRACON Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of products for cancer treatment, announced an agreement granting TRACON exclusive worldwide rights to develop and commercialize ...
-
Morphotek Obtains Exclusive License from Micromet for Antibody to Treat Melanoma and Other Cancers
(14 Feb 2007)
Micromet, Inc. and Morphotek(R) Inc. announced that Morphotek exercised its option under a 2004 agreement to obtain an exclusive worldwide license for an antibody targeting an antigen with potential activity for the treatment of certain cancers, ...
Additional information
Micromet Inc.
Bethesda, MD, United States of America
Company
|
|
|
|
|
|
Top
